Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Cantor Fitzgerald
Chubb
Teva
Medtronic
McKesson
AstraZeneca
Citi
Johnson and Johnson
Queensland Health

Generated: February 25, 2018

DrugPatentWatch Database Preview

Nortriptyline hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for nortriptyline hydrochloride and what is the scope of nortriptyline hydrochloride patent protection?

Nortriptyline hydrochloride
is the generic ingredient in four branded drugs marketed by Lilly, Aurolife Pharma Llc, Idt Australia Ltd, Mayne Pharma, Mylan, Taro Pharm, Teva, Specgx Llc, Ranbaxy, Pharm Assoc, and Taro, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for nortriptyline hydrochloride. Thirty-three suppliers are listed for this compound.
Pharmacology for nortriptyline hydrochloride
Medical Subject Heading (MeSH) Categories for nortriptyline hydrochloride

US Patents and Regulatory Information for nortriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 073553-001 Mar 30, 1992 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Idt Australia Ltd NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074054-002 Dec 31, 1992 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074132-001 Mar 27, 1995 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 074234-004 Jul 26, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-004 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 073667-001 Apr 11, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 073667-003 Apr 11, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharm Assoc NORTRIPTYLINE HYDROCHLORIDE nortriptyline hydrochloride SOLUTION;ORAL 075606-001 Aug 28, 2000 AA RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Ranbaxy AVENTYL nortriptyline hydrochloride SOLUTION;ORAL 014685-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-002 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for nortriptyline hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-004 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Ranbaxy AVENTYL nortriptyline hydrochloride SOLUTION;ORAL 014685-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride SOLUTION;ORAL 018012-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-003 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Lilly AVENTYL HYDROCHLORIDE nortriptyline hydrochloride CAPSULE;ORAL 014684-002 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Specgx Llc PAMELOR nortriptyline hydrochloride CAPSULE;ORAL 018013-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Moodys
QuintilesIMS
Accenture
Healthtrust
Express Scripts
Harvard Business School
Argus Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot